{
    "2021-10-25": [
        [
            {
                "time": "2021-10-25",
                "original_text": "最 高 涨 近 七 成 ！ 券 商 最 新 调 研 偏 爱 这 些 股",
                "features": {
                    "keywords": [
                        "券商",
                        "调研",
                        "偏爱",
                        "股票"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "医 药 赛 道 明 显 回 调 ， 是 否 迎 来 布 局 窗 口 ？",
                "features": {
                    "keywords": [
                        "医药",
                        "赛道",
                        "回调",
                        "布局窗口"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "关 注 低 估 值 、 低 位 置 血 制 品 、 消 费 医 疗 板 块 ， 重 点 推 荐 博 雅 生 物 、 鱼 跃 医 疗 等 ! 【 东 吴 医 药 朱 国 广 团 队 】",
                "features": {
                    "keywords": [
                        "低估值",
                        "血制品",
                        "消费医疗",
                        "博雅生物",
                        "鱼跃医疗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "张 坤 和 千 亿 高 瓴 全 跑 了 ， 2 5 0 0 亿 “ 眼 茅 ” 业 绩 突 然 下 滑 ！ 盈 利 能 力 下 降",
                "features": {
                    "keywords": [
                        "张坤",
                        "高瓴",
                        "眼茅",
                        "业绩下滑",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "医 药 生 物 行 业 跨 市 场 周 报 ： 关 注 高 景 气 度 赛 道 的 超 预 期 机 会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "周报",
                        "高景气度",
                        "超预期机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "迈 瑞 医 疗 ： 公 司 有 新 冠 抗 体 检 测 试 剂 ， 目 前 已 经 拿 到 C E 以 及 其 他 境 外 多 国 的 注 册 证 ， 主 要 是 在 海 外 销 售",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "新冠抗体",
                        "CE认证",
                        "海外销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "罕 见 ！ 超 6 0 0 家 机 构 扎 堆 调 研 、 1 7 家 百 亿 私 募 现 身 4 4 0 0 亿 “ 药 器 茅 ” 火 了 ！",
                "features": {
                    "keywords": [
                        "机构调研",
                        "私募",
                        "药械茅",
                        "迈瑞医疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}